Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bayo

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 2, 2020
SEOM clinical guideline for secondary prevention (2019)A Santaballa, Á Pinto, R P Balanyà, et al.
Anales Del Sistema Sanitario De Navarra|July 30, 2003
[Study of the accumulation of lead in the primary teeth]I Aguinaga, E Manso, F Guillén, et al.
Advances in Therapy|September 17, 2011
Initialization of adjuvant hormonal treatment for breast cancerA Martínez Guisado, A Sánchez Muñoz, M de la Cabeza Lomas Garrido, et al.
Gene Therapy|November 21, 2014
SPARC (secreted protein acidic and rich in cysteine) knockdown protects mice from acute liver injury by reducing vascular endothelial cell damageE Peixoto, C Atorrasagasti, J B Aquino, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 15, 2014
Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancerJ Salvador, L Manso, J de la Haba, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 2, 2020
SEOM clinical guideline for secondary prevention (2019)A Santaballa, Á Pinto, R P Balanyà, et al.
Anales Del Sistema Sanitario De Navarra|July 30, 2003
[Study of the accumulation of lead in the primary teeth]I Aguinaga, E Manso, F Guillén, et al.
Advances in Therapy|September 17, 2011
Initialization of adjuvant hormonal treatment for breast cancerA Martínez Guisado, A Sánchez Muñoz, M de la Cabeza Lomas Garrido, et al.
Gene Therapy|November 21, 2014
SPARC (secreted protein acidic and rich in cysteine) knockdown protects mice from acute liver injury by reducing vascular endothelial cell damageE Peixoto, C Atorrasagasti, J B Aquino, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 15, 2014
Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancerJ Salvador, L Manso, J de la Haba, et al.
Pageof 3